Redeye: Proact - Streamlining the Organization
Redeye retains its positive view of Proact following a solid Q2 report, with the positive highlights being strong organic growth in recurring revenue and low SG&A. System revenue, as well as the intake of new cloud contracts, were somewhat soft. We raise our Base Case and forecasts slightly.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/